The root causes of diseases like cancer, dementia and heart disease are expected to be better understood following a ...

Among the most widely used tools today to measure the deterioration of the organism over time are the so-called "epigenetic ...

AI has led to breakthroughs in synthetic biology, whose promise ranges from new drugs that perform better to replacements for ...

The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...

The root causes of diseases like cancer, dementia and heart disease are expected to be better understood following a “significant” research partnership involving an Indian-origin entrepreneur’s ...

Gordon Sanghera, CEO of Oxford Nanopore Technologies, said the development of a world-first “epigenetic map” of the human ...

As the NHS explores extended genetic screening for newborns, Paul Dinsdale investigates the perils and pitfalls of genomic ...

Californians are living longer and the state’s aging population has forced policymakers to focus more on the growing ranks of ...

In 1964, two years after he became dean of CMU’s Graduate School of Industrial Administration, Richard Cyert was teaching in ...

Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...